Invus Public Equities, L.P. 13D and 13G filings for Silence Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 4:31 pm Purchase |
2024-09-30 | 13G | Silence Therapeutics plc SLN |
Invus Public Equities, L.P. | 8,495,310 6.100% |
156,453 (+1.88%) |
Filing |
| 2024-08-02 6:51 pm Purchase |
2024-07-25 | 13G | Silence Therapeutics plc SLN |
Invus Public Equities, L.P. | 8,338,857 6.000% |
8,338,857 (New Position) |
Filing |